Showing 1 - 10 of 1,524
The aim of this paper is to test whether patent-based indicators are still reliable measures of innovativeness in light of organizational changes in the field of Intellectual Property Rights (IPR) protection and the regulatory reforms already under way respectively at the U.S. Patent and...
Persistent link: https://www.econbiz.de/10010263794
This paper provides evidence on the mechanisms influencing the patent output of a sample of biotechnology firms from the input of indirect knowledge acquired from capital expenditures and direct knowledge from in-house R&D. Statistical models of counts are used to analyse the relationship...
Persistent link: https://www.econbiz.de/10011981924
In the pharmaceutical industry, firms frequently engage in licensing agreements to overcome innovation challenges and keep up with the pace of developing new drugs. Licensing helps firms jointly develop new drugs and acquire external knowledge, which helps improve their internal drug...
Persistent link: https://www.econbiz.de/10012219514
Pharmaceutical firms typically enjoy market exclusivity for new drugs from concurrent protection of the underlying invention (through patents) and the clinical trials data submitted for market approval (through data exclusivity). Patent invalidation during drug development renders data...
Persistent link: https://www.econbiz.de/10012064786
This paper discusses the impact of a firm's technology portfolio on its market value. Two concepts are used to characterize a firm's portfolio: the number of technological fields and the degree of relatedness within the portfolio characterized by the amount of joint occurrences of patents in...
Persistent link: https://www.econbiz.de/10010265003
Technological change is often hypothesized as one of the main drivers of merger activities. This paper analyzes the role of technology in mergers and acquisitions (M&As) at the firm level. Based on a newly created data set that combines financial information and patent data for public limited...
Persistent link: https://www.econbiz.de/10010295834
scope, their relationships, the size-scaling and coherence properties of diversification itself. Our analysis shows that … technologies increase log-linearly with firm size. And the directions of diversification themselves display coherence between …
Persistent link: https://www.econbiz.de/10010502699
scope, their relationships, the size-scaling and coherence properties of diversification itself. Our analysis shows that … technologies increase log-linearly with firm size. And the directions of diversification themselves display coherence between …
Persistent link: https://www.econbiz.de/10011715822
This paper explores the sources of firm-level scale economies in R&D, based on unique project-level data from a new large-scale survey of Japanese inventors, matched with firmlevel data. We focus on four sources: complementary assets, internal and external knowledge inflows, and inventor team...
Persistent link: https://www.econbiz.de/10009154534
This paper discusses the impact of a firm's technology portfolio on its market value. Two concepts are used to characterize a firm's portfolio: the number of technological fields and the degree of relatedness within the portfolio characterized by the amount of joint occurrences of patents in...
Persistent link: https://www.econbiz.de/10003726020